Simplivia Attends GERPAC 2022Simplivia recently attended the 25th European Conference of the European Society of Hospital Pharmaceutical Technologies (GERPAC 2022).October 20, 2022
Next-Generation CSTD Portfolio Simplivia recently attended the 25th European Conference of the European Society of Hospital Pharmaceutical Technologies (GERPAC 2022) in Hyères, France. Simplivia offers the innovative Chemfort® closed system drug-transfer device (CSTD) preparation portfolio. Chemfort® is a complete next-generation CSTD solution for handling hazardous drugs safely. Chemfort® suits any drug handling protocol and is compatible with all known hazardous drugs. The Simplivia Team at GERPAC 2022
A Full Vial-to-Vein Solution Simplivia also designs and manufactures the Chemfort® closed administration portfolio - a new, full vial-to-vein solution that provides safety for nurses who work with hazardous drugs. Simplivia’s Chemfort® preparation and closed administration product lines are backed by peer-reviewed articles demonstrating the efficacy of Simplivia’s Toxi-Guard® air-cleaning technology.
Safety for Healthcare Professionals At GERPAC 2022, we also had the pleasure of meeting a wide range of potential partners, including oncology and hospital pharmacists, academics, research workers and representatives of the pharma industry. At Simplivia, we continue to develop leading, innovative solutions to ensure safety for healthcare professionals in hospital pharmaceutical environments where toxic drugs are prepared. Follow Simplivia on LinkedIn and at www.simplivia.com.